NCT01407497 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine


Sponsors: Instituto Nacional de Saúde, Mozambique Swedish Institute for Communicable Disease Control, Sweden European and Developing Countries Clinical Trials Partnership (EDCTP)	Phases: Phase I
Indications	Acronym:
HIV Infections
Age Groups: Adult	Gender: Both
Names: Biological: DNA HIVIS and MVA-CMDR Biological: DNA HIVIS and MVA-CMDR Biological: Saline solution Biological: Saline solution	Enrollment: 24

Additional information about NCT01407497.